In animal models of ALS, a disease that causes paralysis and eventual death due to loss of upper and lower motor neurons, PPARγ agonists extend survival and attenuate motor neuron loss (Kiaei et al., 2005; Shibata et al., 2008). The gene discussed is PPARG; the disease is amyotrophic lateral sclerosis.